Procter & Gamble Hygiene and Health Care Ltd. (PGHH) announced its financial results for the second quarter ended September 30, 2026. The company reported sales of ₹1145 crore, which remained flat year-over-year. Profit After Tax (PAT) stood at ₹196 crore, a decrease of 7% compared to the same period last year. The company cited commodity cost fluctuations and unfavorable foreign exchange rates as factors impacting profitability, partially offset by a robust productivity program.
Procter & Gamble Hygiene and Health Care Ltd. Announces Q2 FY27 Financial Results
Procter & Gamble Hygiene and Health Care Ltd. (PGHH) has officially released its financial results for the second quarter and the first half of the fiscal year ending September 30, 2026. The company reported total sales amounting to ₹1145 crore, indicating a flat performance compared to the previous year’s corresponding quarter. The Profit After Tax (PAT) for the quarter was reported at ₹196 crore, reflecting a 7% decline year-over-year.
Factors Influencing Performance
The company’s performance in the quarter was impacted by a double-digit effect from commodity cost fluctuations and headwinds related to raw material and energy costs, alongside unfavorable foreign exchange rates. However, these challenges were significantly mitigated by the company’s ongoing and effective productivity program. PGHH also continued to make substantial investments in innovation and advertising & promotion during the quarter, aiming to strengthen its long-term competitiveness and value creation capabilities.
Strategic Outlook and Brand Focus
Kumar Venkatasubramanian, Managing Director of Procter & Gamble Hygiene and Health Care Ltd., stated that the company is strategically investing in its brands, innovation, and market capabilities despite a challenging macro-economic landscape. He expressed confidence that the company’s strategic priorities, coupled with the strength of its brands and organizational capabilities, position it well to capitalize on future growth opportunities and deliver sustainable long-term value for all stakeholders. The company is particularly excited about its future prospects.
He further elaborated on the company’s Integrated Growth Strategy, which focuses on a product portfolio centered on daily use categories. This strategy emphasizes superior product performance, packaging, brand communication, retail execution, and value, alongside productivity enhancements, constructive disruption, and an agile, accountable organization to achieve balanced growth and value creation.
Key Milestones and Initiatives
The first half of FY 2026–27 has been marked by sustained innovation across key areas. Notable achievements include the launch of upgraded products such as Vicks ZzzQuil with Ashwagandha and Vicks medicated lozenges. The company is also continuously evolving its media model to enhance consumer engagement. Furthermore, PGHH is driving its Whisper Period Pants initiative to offer consumers enhanced 360-degree leakage protection. Recently, the company participated in P&G Loop, a large-scale immersive brand experience event designed for content creators.
About Procter & Gamble Hygiene and Health Care Limited
Procter & Gamble Hygiene and Health Care Ltd. is recognized as one of India’s leading Fast-Moving Consumer Goods (FMCG) companies. Its portfolio includes prominent brands such as Whisper, India’s leading Feminine Hygiene brand, and VICKS, India’s No. 1 Health Care brand, along with Old Spice. The company has built a reputation for delivering high-quality, value-added products designed to meet consumer needs. PGHH is committed to improving the lives of Indian consumers daily through superior value propositions. The company’s brands actively participate in social initiatives, including P&G Shiksha, P&G India’s flagship CSR program supporting the education of underprivileged children in India. For the latest news, please visit in.pg.com.
For further details, please contact Madison Public Relations: Malika Bhavnani at +91 9820496099 or via email at [email protected].
Source: BSE
